Blood News and Research

RSS

Vaccines remain the most effective way to protect against COVID-19 Delta variant, study says

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant of concern dominant in the UK today, according to a study from the University of Oxford.

19 Aug 2021

Antihypertensives may improve survival for patients with colorectal cancer

Common blood-pressure drugs may improve survival for patients with colorectal cancer, a new study suggests.

19 Aug 2021

Excess sedentary leisure time associated with higher risk of stroke

Adults younger than age 60 whose days are filled with sedentary leisure time (which includes using the computer, TV, or reading) and little physical activity have a higher stroke risk than people who are more physically active, according to new research.

19 Aug 2021

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.

19 Aug 2021

Arteriolar niche used by breast cancer cells to prepare for metastasis

More than 43,000 American women will die from breast cancer this year. Most of those deaths will occur after the cancer has spread to other organs, a process called metastasis. This involves at least five major steps.

19 Aug 2021

Study: Any form of exercise may not be the most effective prognostic tool for heart failure patients

While exercise therapy for heart failure (HF) patients with low heart function has been shown to be an effective prognostic tool, the level and format of exercise that yields optimal effects is still unclear.

19 Aug 2021

UT Health San Antonio professors urge uplifting US Latinos from obscurity to the forefront of health care

It is essential to lift the nation's Latino population from obscurity to the forefront of health care, public health intervention and societal presence, three professors from The University of Texas Health Science Center at San Antonio argue in a powerful commentary published Aug. 17 by the Journal of the American Medical Association.

19 Aug 2021

New discovery offers several approaches to fight visceral obesity

Pioneering mouse study offers new therapeutic avenues for reducing visceral fat stores, which have been associated with cardiovascular disease and multiple types of cancer.

18 Aug 2021

Remote controlling of CAR-T cells with heat to precisely target tumors

A team of researchers led by bioengineers at the Georgia Institute of Technology is expanding the precision and ability of a revolutionary immunotherapy that is already transforming oncology. CAR T-Cell therapy has been hailed by patients, clinical-researchers, investors, and the media as a viable cure for some cancers.

18 Aug 2021

Researchers create the first 3D-bioprinted model of active glioblastoma tumor

A scientific achievement for researchers at Tel Aviv University: printing an entire active and viable glioblastoma tumor using a 3D printer.

18 Aug 2021

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Aug 2021

SARS-CoV-2 ORF8 and the expression of cytokine in human macrophages

A new study has determined the production of the SARS-CoV-2 SP-dependent ORF8.

18 Aug 2021

Study shows how mesenchymal stromal cells regulate factors driving inflammation in COPD patients

A new phase I clinical study shows, for the first time, how treatment with a type of stem cell called mesenchymal stromal cells is able to regulate important factors driving inflammation in patients with chronic obstructive pulmonary disease (COPD) for a period for time.

18 Aug 2021

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.

18 Aug 2021

The White House says boosters for all. Here’s what you need to know.

The Biden administration announced plans Wednesday to offer boosters to all U.S. adults as soon as next month, saying that recent data, including some made available only in the past few days, played a role in that decision.

18 Aug 2021

Study examines prevalence of neutralizing antibodies to HCoV-NL63 in healthy adults in Australia

A new study has been published in the MPDI journal Viruses, which focuses on determining the seroprevalence of neutralizing antibodies against HCoV-NL63, in healthy adults, in a cross-sectional study.

18 Aug 2021

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

A CRISPR screening tool identified a new therapeutic target to treat acute myeloid leukemia (AML) that has the potential to leave patients with fewer side effects than current approaches, according to a new study from Penn Medicine published online in Molecular Cell.

18 Aug 2021

Science shows mask-wearing is largely safe for children

Florida Gov. Ron DeSantis is one of a handful of Republican governors trying to block school districts from requiring masks in the classroom.

18 Aug 2021

Rush to boosters sparks confusion, differing recommendations

When the Food and Drug Administration announced last week that a third dose of Moderna or Pfizer-BioNTech covid-19 vaccine may boost the immunity of some people who are immunocompromised, officials repeated their stance that fully vaccinated, healthy people do not need another dose.

18 Aug 2021

Federal vaccine program hasn’t helped those whose lives were altered by covid shot

Angela Marie Wulbrecht jumped at the first chance to get a covid-19 vaccine, driving three hours from her Santa Rosa, California, home to a mass-vaccination site on Jan. 19.

18 Aug 2021

Blood News and Research

Vaccines remain the most effective way to protect against COVID-19 Delta variant, study says

Antihypertensives may improve survival for patients with colorectal cancer

Excess sedentary leisure time associated with higher risk of stroke

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

Arteriolar niche used by breast cancer cells to prepare for metastasis

Study: Any form of exercise may not be the most effective prognostic tool for heart failure patients

UT Health San Antonio professors urge uplifting US Latinos from obscurity to the forefront of health care

New discovery offers several approaches to fight visceral obesity

Remote controlling of CAR-T cells with heat to precisely target tumors

Researchers create the first 3D-bioprinted model of active glioblastoma tumor

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

SARS-CoV-2 ORF8 and the expression of cytokine in human macrophages

Study shows how mesenchymal stromal cells regulate factors driving inflammation in COPD patients

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

The White House says boosters for all. Here’s what you need to know.

Study examines prevalence of neutralizing antibodies to HCoV-NL63 in healthy adults in Australia

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

Science shows mask-wearing is largely safe for children

Rush to boosters sparks confusion, differing recommendations

Federal vaccine program hasn’t helped those whose lives were altered by covid shot

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News